Atlas Trials

Germ Cell Tumors

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Germ Cell Tumors

RecordFirmDate
Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies (NCT04648826)National Cancer Institute (NCI)2021-12-14
Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors. (NCT04283773)Assiut University2019-12-24
Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors (NCT03726281)Hospital Beatriz Ângelo2018-10-01
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors (NCT02536183)AeRang Kim2016-10-01
Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors (NCT02689219)Nabil Adra2016-03-09
Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors (NCT02390843)Emory University2015-02-01
Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors (NCT01873326)Memorial Sloan Kettering Cancer Center2013-06-01
Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors (NCT01743482)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano2013-05-17
Auto Transplant for High Risk or Relapsed Solid or CNS Tumors (NCT01505569)Masonic Cancer Center, University of Minnesota2011-10-20
Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis (NCT00864318)Institut Claudius Regaud2009-03-13
Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors (NCT00572572)Hoosier Cancer Research Network2007-12-01
Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy (NCT00187109)St. Jude Children's Research Hospital2000-06-01
Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors (NCT02161692)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano1996-12-01

Track Germ Cell Tumors automatically

Every clearance here is in the API, with alerts when new ones post.